Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins and monitoring of liver function tests.

× No keyword cloud information.

16 in total

Review 1. Statins and hepatotoxicity: focus on patients with fatty liver.

Authors: Naga Chalasani
Journal: Hepatology Date: 2005-04 Impact factor: 17.425

2. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

Authors: James M McKenney; Michael H Davidson; Terry A Jacobson; John R Guyton
Journal: Am J Cardiol Date: 2006-02-28 Impact factor: 2.778

3. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.

Authors: James Shepherd; Philip Barter; Rafael Carmena; Prakash Deedwania; Jean-Charles Fruchart; Steven Haffner; Judith Hsia; Andrei Breazna; John LaRosa; Scott Grundy; David Waters
Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112

4. Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization.

Authors: Evguenia C Charles; Kari L Olson; Brian G Sandhoff; David L McClure; John A Merenich
Journal: Am J Med Date: 2005-06 Impact factor: 4.965

5. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.

Authors: Jean Rouleau
Journal: Am J Med Date: 2005-12 Impact factor: 4.965

6. Statin safety: lessons from new drug applications for marketed statins.

Authors: Terry A Jacobson
Journal: Am J Cardiol Date: 2006-02-02 Impact factor: 2.778

Review 7. Statin safety: a systematic review.

Authors: Malcolm Law; Alicja R Rudnicka
Journal: Am J Cardiol Date: 2006-02-03 Impact factor: 2.778

8. Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin.

Authors: Aukje K Mantel-Teeuwisse; Olaf H Klungel; Toine C G Egberts; W M Monique Verschuren; Arijan J Porsius; Anthonius de Boer
Journal: Drug Saf Date: 2004 Impact factor: 5.606

9. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.

Authors: Naga Chalasani; Hisham Aljadhey; Joe Kesterson; Michael D Murray; Stephen D Hall
Journal: Gastroenterology Date: 2004-05 Impact factor: 22.682

Review 10. The liver and lovastatin.

Authors: Keith G Tolman
Journal: Am J Cardiol Date: 2002-06-15 Impact factor: 2.778